Imagine world were a vaccine tailored to a specific patient was administered to kill cancerous cells. Well this world might be soon to come. Two studies were successful in produce a vaccine that prevented early relapse among twelve people with melanoma skin cancer. Earlier studies targeted a single type of protein found within the cancer cells that was shared among patients. However, with the new vaccine the mutated cancerous cells specific to a person are target allowing healthy cells to be spared. Check out the article here!
By Julia Watson